Olga Granaturova

Olga Granaturova has a diverse and extensive work experience in the life science industry. Olga is currently the COO and CBO at Normunity since 2023. Prior to that, they co-founded Parthenon Therapeutics in 2019 and held the roles of Co-Founder, Board Member, and COO/CBO. Olga also co-founded Brighter Ventures in 2018, focusing on advancing women-led entrepreneurship. Olga has a strong background in consulting and management, as they founded and served as the Managing Partner of LENUS Group from 2012 onwards, providing strategic advisory services to the life science industry. Olga has held positions at Evotec as the Vice President of Strategic Business Development and at LUCIDITAI as the Co-Founder and CEO. Furthermore, Olga worked at Ludwig-Maximilians Universität München as the Director of the Postgraduate Drug Development Program and at Merck as Global Strategic Regulatory Development Liaison. Olga gained valuable experience as a Principal Investigator and Business Development personnel at MDS Pharma Services and as a Scientist in the DMPK division at Pfizer. Olga Granaturova's career demonstrates their expertise and leadership in various roles within the life science industry.

Olga Granaturova's education history includes a Master of Business Administration (M.B.A.) degree with a focus on Global Executive MBA from TRIUM Global Executive MBA, HEC Paris, NYU Stern School of Business, and The London School of Economics and Political Science (LSE), earned between 2013 and 2015. Additionally, they hold a Bachelor's degree in Pharmaceutical Sciences from the University at Buffalo's School of Pharmacy, which they obtained from 2000 to 2005.